TrialBMC cancer2024

Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.

Arash O Naghavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.